GSK plc
GSK- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001131399
No open-market purchases or sales by GSK plc insiders were filed in the last 90 days; 1,048 institutions reported holding it in 13F filings for Q2 2026, worth $18.2B in total; no superinvestor holds it.
Other share classesGLAXF
Q3 2023 vs. Q2 2023
How the institutions holding GSK plc changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 829 | 11 | 849 | +31 |
| Shares | 278.0M | 103.0K | 285.9M | +7.95M (+2.9%) |
| Value | $9.91B | $3.67M | $10.4B | +$456.6M (+4.6%) |
11 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (100)
Institutions that held GSK plc at the end of Q3 2023 but not at the end of Q2 2023.
Sold out (69)
Institutions that held GSK plc at the end of Q2 2023 and filed for Q3 2023 without it.
Not filed for Q3 2023 yet (11)
Institutions that held GSK plc at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Tekla Capital Management LLC | 41,852 | $1.49M |
| Northwest Bank & Trust Co | 23,115 | $823.5K |
| BFT Financial Group, LLC | 19,118 | $681.4K |
| Kistler-Tiffany Companies, LLC | 14,064 | $501.2K |
| BDO Wealth Advisors, LLC | 1,945 | $69.3K |
| First National Bank of South Miami | 725 | $25.8K |
| Endurance Wealth Management, Inc. | 587 | $21.0K |
| BerganKDV Wealth Management, LLC | 560 | $20.0K |
| First Command Bank | 458 | $16.3K |
| First Command Financial Services, Inc. | 458 | $16.3K |
| Coastal Capital Group, Inc. | 109 | $3.88K |